We had intended to use an individual’s monthly average CPAP treatment adherence since the previous assessment as a covariate in analyses one to four, and for contamination-adjusted intention-to-treat analyses (planned analyses six to eight). However, data extracted from CPAP machines used in this trial were captured as summative across the trial period and not on a month-by-month basis, preventing us from being able to use this variable for these analyses. Planned analyses six to eight described in the protocol were not undertaken. One participant was recruited into the study but after further analysis of the overnight sleep study, was found to have only mild OSA and was therefore excluded from all analyses.
We undertook a post-hoc sensitivity analysis for comparisons of weight between intervention and control periods using raw weight as the dependent variable instead of change in weight from the previous assessment to assist with interpretation of the effect size estimates generated. We examined whether those who continued use of CPAP had different mean weight scores at 12-month follow-up compared to those who did not commence or discontinued CPAP, adjusted for weight at the baseline assessment using linear regression.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.